SMTL ID : 5l6p.1

EphB3 kinase domain covalently bound to an irreversible inhibitor (compound 6)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.26 Å

Oligo State

monomer

Ligands

1 x 6P8: ~{N}-(4-phenylazanylquinazolin-7-yl)ethanamide(Covalent)

6P8.1: 14 residues within 4Å: Chain A: I.27, A.51, K.53, M.74, T.99, E.100, F.101, M.102, C.105, L.153, S.163, D.164, F.165, G.166 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:I.27, A:K.53, A:F.101, A:L.153 Hydrogen bonds: A:T.99, A:M.102

1 x DIO: 1,4-DIETHYLENE DIOXIDE(Non-covalent)

DIO.2: 8 residues within 4Å: Chain A: M.74, F.77, I.82, I.83, Y.142, H.144, V.162, F.165 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kung, A. et al., Development of Specific, Irreversible Inhibitors for a Receptor Tyrosine Kinase EphB3. J.Am.Chem.Soc. (2016)

Release Date

2016-08-10

Peptides

Ephrin type-B receptor 3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Ephrin type-B receptor 3

Related Entries With Identical Sequence